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The article by Aiso et al. titled “Compared with the intake of commercial vegetable juice, the intake of fresh fruit
and komatsuna (Brassica rapa L. var perviridis) juice mixture reduces serum cholesterol in middle-aged men: a
randomized controlled pilot study” does not meet the expected standards of Lipids in Health and Disease. Although
the article concludes that there are some significant benefits to their komatsuna juice mixture, these claims are not
supported by the statistical analyses used. An incorrect procedure was used to compare the differences in two
treatment groups over time, and a large number of outcomes were tested without correction; both issues are
known to produce high rates of false positives, making the conclusions of the study unjustified. The study also fails
to follow published journal standards regarding clinical trial registration and reporting.
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The conduct of rigorous randomized controlled trials
(RCTs) is essential for progress in nutrition-related
research [1]. In particular, rigorous tests of the causal
effects of fruit and vegetable consumption on aspects of
health would be valuable [2]. We therefore read with
interest the paper by Aiso et al. [3] reporting results of
an RCT of the effects of consumption of a commercial
vegetable juice to that of the intake of fresh fruit and
komatsuna (Brassica rapa L. var. perviridis) juice on
serum cholesterol in men. Unfortunately, upon reading
it became clear that incorrect statistical analyses were
used, that the conclusions drawn in the paper are not
supported by the analyses reported, and that there is
insufficient adherence to RCT reporting guidelines [4],
making it further difficult to determine the appropriate-
ness of the analyses and the extent to which they adhere
to original analytic plans.* Correspondence: dallison@uab.edu
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The authors conclude “Compared with the intake of
commercial vegetable juice, the intake of fresh fruit and
B. rapa juice is highly effective in reducing serum chol-
esterol.” As we will show below, this conclusion is not
supported by the data and analyses presented.Why the analysis is incorrect
The stated goal of this study was to compare the effects
of the two types of juices on anthropometric data, blood
constituents, and dietary intake. To do so, the authors
performed paired tests (baseline versus after 4 weeks)
within each treatment group, and declared a significant
difference between the juices when one juice’s test came
up significant and the other juice’s test did not. This
analysis strategy is frequently used in published litera-
ture, but is not statistically valid and can result in a
type-1 error rate as high as 50% in trials with two groups
[5]. As Allison et al. [6] wrote, given a parallel-groups
RCT with measures of a continuous outcome at baseline
and at endpoint; there are at least four legitimate ways
to formally test the difference between two groups: (a)
ignore the baseline data and analyze the endpoint data
only with a simple independent samples t-test; (b) use a
repeated measures ANOVA with one between-groupsis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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factor (time) and test the group-by-time interaction
(Yij = β0 + β1Treatmenti + β2Timej + β3TreatmentiTimej +
eij for i = 1,…,N, j = 0, 1, and {eij} has a multivariate nor-
mal distribution) [7, 8]; (c) analyze change scores (i.e.,
endpoint measurement minus baseline measurement)
with a simple independent samples t-test; or (d)
analyze the final outcome as an ANCOVA with one
between-groups factor (treatment assignment) and
one covariate (baseline scores) [9]. More details on
these methods can be found in many classic experi-
mental design books [7, 9, 10] and tutorial papers
[6, 8, 10, 11]. Of note, method (d) (ANCOVA) is
typically more powerful than method (c) (t-test on change
scores) as it uses the observed pre-post correlation to
more efficiently reduce the residual variance [11–13].
Why the conclusions of the paper are not supported
Because a proper test between groups was not reported,
we emailed the corresponding author of the paper, ex-
plained the statistical concern, and requested the stand-
ard deviation for the change in LDL-cholesterol and
change in total cholesterol in each group or that they
make the raw data available thereby allowing us to cal-
culate the values ourselves. Unfortunately, we received
no reply to our request. The ICMJE guidelines (http://
www.icmje.org/icmje-recommendations.pdf ) state “au-
thors have a responsibility to respond appropriately and
cooperate with any requests from the journal for data or
additional information should questions about the paper
arise after publication.” Given this, we suggest that Aiso
et al. make the raw data from this trial available so that
others may verify the results.
Although appropriate between-groups tests of the
effects of treatment assignment on the key outcome var-
iables were not reported, it seems unlikely that many of
such tests could be significant. For total and LDL choles-
terol on which Aiso et al’s conclusion claim is based,
Aiso et al. do report the means and standard deviations
for each variable within each of the treatment and
control groups both at baseline and at endpoint.
Using this information, we can implement choice a
above1. If we do this for total cholesterol, the two-
tailed p-value is 0.9480 (t = 0.0663; df = 14). If we do
this for LDL cholesterol, the two-tailed p-value is
0.5525 (t = 0.6087; df = 14). In neither case is the result
even close to significant, meaning that by this legitimate
test, the appropriate conclusion would have been that
there was no compelling evidence of a treatment effect.
Admittedly, the t-test only on endpoints is a relatively
low power test; choice c above (a t-test on change scores)
will usually be more powerful. Although it is clear that
such a t-test would not be significant for LDL cholesterol
(the groups had identical 9 mg/dl reductions), it isconceivable that the difference between the two groups in
change of total cholesterol is statistically significant but we
lack necessary information (such as the standard deviation
of the change score) to conduct such a test. If Aiso et al.
can show a statistically significant between-groups differ-
ence in the outcome variable, then their conclusion would
be supported, but at present it is unsupported.
There is a concern regarding Aiso et al.’s reporting of
p-values from 58 variables per treatment group (116
tests overall). Such a high number of tests would
strongly suggest the use of a multiple testing correction
to control the type-1 error rate [14] as one may expect
approximately 5.8 significant findings to occur by chance
alone if one tests 116 independent tests with a signifi-
cance level of 0.05 and all the null hypotheses are true
(i.e., there is really nothing to find). The smallest re-
ported p-value was 0.012, far larger than what would be
needed for significance under a Bonferroni (0.000431) or
Sidak [15] (0.000442) correction. Although correlation
between the 58 variables may reduce the extent of Type
I error inflation and methods exist for correcting
multiple correlated outcomes [16], those methods were
not used in this article and without knowing the corre-
lation between each variable it is impossible to quantify
the extent of the inflation. Taken as a whole, it is plau-
sible that many of the p-values reported as significant
represent type-1 errors.
Lack of trial registration
Articles published in Lipids in Health and Disease
require adherence to BioMed Central’s editorial policies,
http://www.lipidworld.com/about. BioMed Central fol-
lows the International Committee of Medical Journal
Editors (ICMJE) guidelines, which necessitate clinical tri-
als registration for RCT reports submitted to its jour-
nals. ICMJE defines a clinical trial as, “any research
study that prospectively assigns human participants or
groups of humans to one or more health-related inter-
ventions to evaluate the effects on health outcomes”
[17]. ICMJE recommends that authors include the trial
registration number in the abstract of the manuscript.
This journal article does not include the clinical trials
registration number. We emailed the authors to inquire
about public clinical trials registry for this article, but re-
ceived no response. Given the above, we believe that the
authors should provide documentation of clinical trial
registration.
Conclusions
Clinicians, scientists, regulators, and the general public re-
quire and have a right to expect scientific evidence based
on valid procedures [18] and free from spin [19] on which
they can base decisions. The Committee on Publication
Ethics [20] states that “Journal editors should consider
Allison et al. Lipids in Health and Disease  (2016) 15:77 Page 3 of 5retracting a publication if…they have clear evidence that
the findings are unreliable [including]… as a result of …
miscalculation or experimental error.” We believe that the
conclusions of Aiso et al. [3] are unreliable as a result of
using an incorrect statistical procedure.Endnotes
1We conducted our calculations with the free pub-
lic software at this site http://www.graphpad.com/
quickcalcs/ttest2/ so that anyone could reproduce our
calculations.Abbreviation
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Here we respond to the commentary on our article by Al-
lison et al. As an overview of the issues they raise, we have
selected the following statement from their commentary.
“Although the article concludes that there are some
significant benefits to their komatsuna juice mixture,
these claims are not supported by the statistical analyses
used. An incorrect procedure was used to compare the
differences in two treatment groups over time such
that no direct between-group comparison was done, anda large number of outcomes were tested without
correction.”
At various points their commentary, they raise questions
about the following aspects of our study: 1) statistical ana-
lysis, 2) dietary survey, and 3) clinical trial registration.
Below, we respond to each of these questions in turn.
Statistical analysis
Before we turn to the detailed statistical issues that Alli-
son et al. raise in their commentary, we would first like
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journal’s referees, both referees specifically stated that
our statistical analysis did not need further verification.
Referee 1 wrote in his/her review:
“Statistical review: No, the manuscript does not need
to be seen by a statistician.”
And Referee 2 wrote in his/her review:
“Statistical review: No, the manuscript does not need
to be seen by a statistician.”
As the referees thought that a statistical review was
unnecessary, we felt confident that we had used the
appropriate statistical methods. Therefore, we were
surprised that our methods were criticized by Allison
et al. However, we were also very interested in their
interpretation, so we followed their suggested method
for analyzing our data.
In their commentary, Allison et al. state:
“The stated goal of this study was to compare the
effects of the two types of juices on anthropometric data,
blood constituents, and dietary intake. To do so, the
authors performed paired tests (baseline versus after 4
weeks) within each treatment group, and declared a sig-
nificant difference between the juices when one juice's
test came up statistically significant (defined by the au-
thors as p<0.05) and the other juice's test did not. This
analysis strategy of comparing nominal significance of
within group changes (done with either paired-sample
parametric or non-parametric tests) is frequently used in
published literature, but is not statistically valid and can
result in a false positive rate as high as 50% in trials with
two groups of equal size.”
and
“there are several legitimate ways to formally test the
difference between two groups: (a), (b), (c).”
[…]
“Method (c) (ANCOVA) is typically more powerful
than method (b) (t-test on change scores). As it uses the
observed pre-post correlation to more efficiently reduce
the residual variance.”
We thank Allison et al. for pointing out this new stat-
istical approach. Like the other researchers in the field,
we were not aware of this more advanced method when
we wrote our paper. However, we were pleased to be
able to apply it to the analysis of our data following the
suggestion of Allison et al. We return to that analysis
below, but first we would like to clarify some issues re-
lated to the Wilcoxon signed rank test that we used in
our study.
The goal of this study was to examine changes in vari-
ous parameters in the intervention group and the con-
trol group before and after their respective juice
interventions. In analyzing our data, we performed both
a paired t-test and a Wilcoxon signed rank test. Both
tests showed that the concentration of total cholesteroland LDL-cholesterol in the intervention group were sig-
nificantly lower after 4 weeks compared with the base-
line values. However, we chose to report the results of
the Wilcoxon signed rank test, as that test is more ap-
propriate for small sample sizes that do not have normal
distributions. In retrospect, we now think that it would
have been clearer to include the reason that we selected
the Wilcoxon test in our article. We apologize for any
misunderstanding that this omission may have caused.
As Allison et al. raised questions about our statistical
methods, we first rechecked the results of our original
statistical analysis. After that, we applied the statistical
analysis that they have suggested.
a. Re-application of Wilcoxon signed rank test.
When we repeated the Wilcoxon signed rank test to en-
sure that the results of our original test were accurate,
we found that the results were the same as those we had
originally published.
b. Application of analysis of covariance (ANCOVA).
In their commentary, Allison et al. state:
“there are several legitimate ways to formally test the
difference between two groups: (a), (b), (c).”
[…]
“Method (c) (ANCOVA) is typically more powerful
than method (b) (t-test on change scores). As it uses the
observed pre-post correlation to more efficiently reduce
the residual variance.”
Following this suggestion, we re-examined our data
using ANCOVA. Data were analyzed using SPSS for
Windows version 15.0 J computer software. We con-
ducted the ANCOVA test by adjusting for levels of
age, BMI, and each variable. The results did not show
a significant difference for the parameters in either
group. We speculate that this may be due to the
small number of subjects participating in the study.
In the light of this new analysis, we think that the
conclusions stated in our original article should be
moderated. We return to this point in our conclusion
below.
Dietary survey
In their commentary, Allison et al. state:
“There is also a concern regarding Aiso et al.’s report-
ing of p-values from 58 variables per treatment group
(116 tests overall).”
We would like to clarify the nature of the dietary survey
used in our study. We used the “brief-type self-
administered diet history questionnaire” (BDHQ), which
is a standard dietary history survey instrument used in
Japan [21, 22]. The BDHQ is used to calculate intake
values such as energy and nutrients based on information
about 58 types of food and drink. The questionnaires are
batch processed at the Diet History Questionnaire
Support Center. Because the Center calculates nutrient
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items and then sends those values to us, we cannot indi-
vidually manipulate the food and drink items as variables
afterwards by ourselves. We can only perform our analysis
based on the data categories provided by the Center, and
therefore we cannot perform a more detailed statistical
analysis on the 58 items.
Clinical trial registration
In their commentary, Allison et al. state:
“The study also fails to follow published reporting
guidelines for this journal and the scientific commu-
nity overall regarding clinical trial registration and
reporting.”
We have registered our study with the UMIN-CTR





The statistical test that we used in our article was
considered appropriate by both of the journal’s re-
viewers. We have rechecked the results of that test,
and have obtained the same result. In addition, we
have carried out the ANCOVA test suggested by Alli-
son et al. ANCOVA did not show a significant differ-
ence between the intervention group and the control
group. We thank Allison et al. for providing us with
this insight. In future studies we plan to increase the
number of subjects and reinvestigate the effect. We
will also consider conducting a crossover study simi-
lar to that of Lee et al. in the future [23].
Based on the insights that we have gained from the
suggestions of Allison et al., we think that the conclusion
originally drawn in our article should be moderated to
be stated as follows:
Compared with the intake of commercial vegetable
juice, the intake of fresh fruit and B. rapa juice may
be effective in reducing serum cholesterol.
We would like to once again thank Dr. Allison and
colleagues for their thoughts on our article.
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